Article
IL-17F facilitates prostate cancer cell malignant phenotypes via activation of the PI3K/AKT signalling pathway.
Andrologia - 1 Nov 2020
Zhu Xu, Zhao Shuli, Ma Xingxin, Cao Zhigang
Abstract excerpt
Prostate cancer (PCa) is known as one of the most common cancers in men all over the world. Previous studies have identified that the pro-inflammatory mediator interleukin-17F (IL-17F) aggravates the progression of several diseases. However, whether IL-17F plays a role in PCa is still lack of enough exploration. In this study, IL-17F expression was strikingly upregulated in PCa tissues. Treatment of IL-17F...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
